Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching, Sarah D. Mahan, Cesear Corona, et al.
ACS Chemical Biology (2018) Vol. 13, Iss. 9, pp. 2758-2770
Open Access | Times Cited: 266

Showing 1-25 of 266 citing articles:

Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem, Craig M. Crews
Cell (2020) Vol. 181, Iss. 1, pp. 102-114
Open Access | Times Cited: 780
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Mariell Pettersson, Craig M. Crews
Drug Discovery Today Technologies (2019) Vol. 31, pp. 15-27
Open Access | Times Cited: 601
PROTACs: great opportunities for academia and industry
Xiuyun Sun, Hongying Gao, Yiqing Yang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 513
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan, Xuan Zhang, Dongwen Lv, et al.
Nature Medicine (2019) Vol. 25, Iss. 12, pp. 1938-1947
Open Access | Times Cited: 503
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva, Craig M. Crews
Current Opinion in Chemical Biology (2019) Vol. 50, pp. 111-119
Open Access | Times Cited: 481
Bromodomains: a new target class for drug development
Andrea G. Cochran, Andrew R. Conery, Robert J. Sims
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 609-628
Closed Access | Times Cited: 377
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Omer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Science (2020) Vol. 368, Iss. 6489, pp. 387-394
Open Access | Times Cited: 353
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 2, pp. 593-598
Open Access | Times Cited: 344
SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate
Michael J. Roy, Sandra Winkler, Scott J. Hughes, et al.
ACS Chemical Biology (2019) Vol. 14, Iss. 3, pp. 361-368
Open Access | Times Cited: 297
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi, Scott J. Hughes, Chiara Maniaci, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 699-726
Open Access | Times Cited: 296
PROTAC Technology: Opportunities and Challenges
Hongying Gao, Xiuyun Sun, Yu Rao
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 3, pp. 237-240
Open Access | Times Cited: 256
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs
Patrick Pfaff, Kusal T. G. Samarasinghe, Craig M. Crews, et al.
ACS Central Science (2019) Vol. 5, Iss. 10, pp. 1682-1690
Open Access | Times Cited: 231
Structure‐Based Design of a Macrocyclic PROTAC
Andrea Testa, Scott J. Hughes, Xavier Lucas, et al.
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 4, pp. 1727-1734
Open Access | Times Cited: 189
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
Sajid Khan, Yonghan He, Xuan Zhang, et al.
Oncogene (2020) Vol. 39, Iss. 26, pp. 4909-4924
Open Access | Times Cited: 189
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 189
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
Satomi Imaide, Kristin M. Riching, Nikolai Makukhin, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 11, pp. 1157-1167
Open Access | Times Cited: 176
Harnessing the Power of Proteolysis for Targeted Protein Inactivation
Rati Verma, Dane Mohl, Raymond J. Deshaies
Molecular Cell (2020) Vol. 77, Iss. 3, pp. 446-460
Open Access | Times Cited: 171
PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes
Daniel Zaidman, Jaime Prilusky, Nir London
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 10, pp. 4894-4903
Open Access | Times Cited: 167
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
Wenhao Guo, Xiaoli Qi, Xin Yu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 165
Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs
Ronen Gabizon, Amit Shraga, Paul Gehrtz, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 27, pp. 11734-11742
Open Access | Times Cited: 164
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu, Craig M. Crews
ChemBioChem (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 159
In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
Michael L. Drummond, Christopher I. Williams
Journal of Chemical Information and Modeling (2019) Vol. 59, Iss. 4, pp. 1634-1644
Open Access | Times Cited: 156
Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
Tao Wu, Hojong Yoon, Yuan Xiong, et al.
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 7, pp. 605-614
Open Access | Times Cited: 153
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
Frances Potjewyd, Anne‐Marie W. Turner, Joshua Beri, et al.
Cell chemical biology (2019) Vol. 27, Iss. 1, pp. 47-56.e15
Open Access | Times Cited: 152
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 152
Page 1 - Next Page

Scroll to top